Smart Money Circle

Adam Sarhan
  • 4.9 (15)
  • Investing
  • Updated Semiweekly

This show interviews the “smart money” (large money managers & CEOs) for timeless investing advice. My goal is to provide you with timeless/actionable advice that you can use to make smarter investment decisions, and help you become intellectually wealthy. The Host: Adam Sarhan, Author, Investor, and Forbes Contributor, interviews real money managers with over $100 million in assets under management (AUM) and CEOs for timeless advice. Disclaimer: All our work is general in nature and for educational/informational purposes only. No specific investment advice is given.

  1. 6d ago

    This CEO Wants To Help Your Nerves Heal Faster. Meet Adam Rogers CEO NervGen – NGEN

    This CEO Wants To Help Your Nerves Heal Faster. Meet Adam Rogers CEO NervGen – NGEN Guest Adam Rogers, MD, Chair, President & Chief Executive Officer at NervGen Adam’s BIO: Adam H. Rogers, MD, is the President and Chief Executive Officer of NervGen Pharma and has served as Chairman of the Company’s Board of Directors since July 2025. Dr. Rogers has more than fifteen years of experience advancing novel therapies for diseases with significant unmet medical need. He is the Principal of Boston-based PFP Biosciences Holdings and previously co-founded Hemera Biosciences in 2010, a clinical-stage biotechnology company developing a one-time investigational gene therapy administered via outpatient intravitreal injection to preserve vision in patients with geographic atrophy, a late-stage and severe form of age-related macular degeneration. He served as Hemera’s Chief Executive Officer from 2017 until December 2020, when the rights to its lead program were acquired by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Earlier in his career, Dr. Rogers served as an Assistant Professor of Ophthalmology at the New England Eye Center at Tufts Medical Center and has authored numerous peer-reviewed publications. Dr. Rogers is a board-certified ophthalmologist specializing in diseases and surgery of the retina and vitreous and holds an MD from Emory University School of Medicine. Company Bio NervGen Pharma (NASDAQ: NGEN) is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. The Company’s mission is to transform the lives of individuals living with SCI by enabling the nervous system to repair itself. NervGen’s lead therapeutic candidate, NVG-291, is a subcutaneously administered, neuroreparative peptide designed to target the inhibitory CSPG-PTPσ pathway. NVG-291 is the first pharmacologic candidate to improve function, independence, and quality of life in chronic tetraplegia, as demonstrated in the Phase 1b/2a CONNECT SCI study. NVG-291 has received Fast Track designation from the FDA and Orphan Drug designation from the European Medicines Agency for the treatment of SCI. Through NVG-291 and the Company’s next-generation candidate, NVG-300, NervGen is pursuing a pharmacologic approach to transform the treatment paradigm for neurotraumatic and neurologic conditions with significant unmet medical need. For more information, visit www.nervgen.com and follow NervGen on X and LinkedIn.

    15 min

  2. Jun 22

    This CEO Is Using Tech To Improve Healthcare & Is Bending The Curve Of Disease. Omada Health $OMDA

    Bio: Sean Duffy is the Co-founder and CEO of Omada Health, a between-visit care provider that addresses cardiometabolic conditions like diabetes, hypertension, prediabetes, and obesity, as well as musculoskeletal issues. He has dedicated his professional life to bridging technology, design, and care delivery to transform care experiences for patients. As a former MD/MBA candidate at Harvard, he also holds a BS in neuroscience from Columbia University. He has written extensively about digital health and the future of healthcare in The New England Journal of Medicine, The Wall Street Journal, Forbes, and TechCrunch, among other publications. Prior to Omada, Sean worked at both Google and IDEO. Company: Omada Health (Nasdaq: OMDA) is reverse engineering the way healthcare is delivered in America, putting the space between doctor visits–where health is won or lost–at the center of care. Today's healthcare system poorly serves chronic conditions that require ongoing support outside of the exam room, like obesity, diabetes, hypertension, cholesterol, and musculoskeletal conditions. Omada’s virtual-first model combines human-led care teams, connected devices, and AI-enabled technology to deliver personalized care at scale, including support for GLP-1 therapy. Omada has served more than two million members since launch across 2,000+ employers, health plans, pharmacy benefit managers, and health systems. Learn more at omadahealth.com.

    14 min

  3. Jun 18

    This CEO Is Helping Companies Advertise On TV, In A Better Way – Meet Mark Douglas CEO Mountain MNTN

    This CEO Is Helping Companies Advertise On TV, In A Better Way – Meet Mark Douglas Mountain- MNTN * Mark Douglas | MNTN President & CEO * Mountain * https://mountain.com/ * NYSE: MNTN Bio: https://mountain.com/about/ About Mark Mark oversees the direction of MNTN with his 20 years of product development experience gained through repeated success in helping fast-growth companies transition into emerging markets. He started at Oracle. Shortly after, Mark founded a series of successful startups resulting in IPOs and acquisitions. He was the VP of Technology at eHarmony where he built personality-matching technology. More recently, Mark built new technology for Rubicon Project as the VP of Engineering. About MNTN: MNTN (NYSE: MNTN) is the Hardest Working Software in Television™, bringing unrivaled performance and simplicity to Connected TV advertising. Our self-serve technology makes running TV ads as easy as search and social and helps brands drive measurable conversions, revenue, site visits, and more. MNTN was named one of Fast Company’s Most Innovative Companies and Next Big Things in Tech, and was recently featured on the cover of INC’s Best in Business Issue. For more information, please visit https://mntn.com/.

    25 min

  4. Jun 16

    This CEO Is Helping Your Brain Function Better- Meet David Stamler, M.D., CEO Alterity Therapeutics $ATHE

    David Stamler, M.D., Chief Executive Officer AlterityTherapeuticsAlterity Therapeutics (NASDAQ: ATHE & ASX: ATH) www.alteritytx.com     David Stamler, M.D., Chief Executive Officer David Stamler, M.D. is Chief Executive Officer and a Managing Director, and previously served as Alterity's Chief Medical Officer and Senior Vice President, Clinical Development. Dr Stamler has extensive drug development expertise spanning early-stage research through late-stage clinical trials, with three FDA drug approvals in neurology. Prior to joining Alterity, Dr. Stamler served as the Vice President, Clinical Development and Therapeutic Head for Movement Disorders at Teva Pharmaceutical Industries after Teva acquired Auspex Pharmaceuticals where he was Chief Medical Officer. Prior to Auspex, he served as Senior Vice President and Chief Medical Officer at XenoPort, Inc., and Head of Drug Development at Prestwick Pharmaceuticals, Inc. Before Prestwick, Dr. Stamler worked at Fujisawa Pharmaceutical Co. and its subsidiaries in various leadership roles, including Vice President, Research and Development, Medical Sciences at Fujisawa Healthcare, Inc., and as Vice President, Clinical Research Center at Fujisawa Research Institute of America. Dr. Stamler began his career at Abbott Laboratories where he served in various positions including Director of Clinical Research, Pharmaceutical Products for the International Division. Dr. Stamler received an M.D. from the University of Chicago—The Pritzker School of Medicine and a B.A. in Biology from the University of Chicago.

    21 min

  5. Jun 12

    This CEO Is Advancing Neuroscience By Treating Pain & Epilepsy – Meet Dave Rosa, CEO, NeuroOne $NMTC

    This CEO Is Advancing Neuroscience, Reducing Pain, & Treating Epilepsy – Meet Dave Rosa, CEO, NeuroOne Medical Technologies $NMTC Guest: Dave Rosa, CEO, NeuroOne Medical Technologies $NMTC Dave's Bio Dave Rosa is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. In addition to CEO roles with early-stage medical device companies, Mr. Rosa’s background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. Mr. Rosa holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University. Mr. Rosa currently serves as the President and CEO of NeuroOne (Nasdaq: NMTC), a medical technology company that develops high-definition, minimally invasive diagnostic and therapeutic devices based on its unique thin film electrode technology. NeuroOne, Nasdaq: NMTC Website https://nmtc1.com Company Bio NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo(R) Cortical Electrodes, Evo(R) sEEG Electrodes, OneRF(R) Ablation System (for brain), and OneRF(R) Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering combination diagnostic and therapeutic functions. The Company is engaged in research and development for drug delivery and spinal cord stimulation programs.

    19 min

  6. Jun 8

    A Different Kind of Police Tool & A Different Kind of Investment Story. Meet Scot Cohen CEO $WRAP

    A Different Kind of Police Tool & A Different Kind of Investment Story. Meet Scot Cohen CEO $WRAP Guest Scot Cohen: CEO & Executive Chairman, Wrap Technologies, Inc. Scot's Bio Co-founder and largest shareholder of Wrap Technologies, Scot Cohen has led the company's strategy and financing since its 2016 founding. He brings 30+ years in asset management and capital markets, having co-founded Iroquois Capital, a New York hedge fund managing approximately $300M. Wrap Technologies, Inc. Website: wrap.com Ticker: Nasdaq: WRAP Company Bio Wrap Technologies is a global public-safety technology company building non-lethal response solutions for law enforcement, security, and defense. The company is rapidly expanding into drone-based public safety, having launched DFR-X, the first U.S. commercially available non-lethal Drone First Responder interdiction system, alongside its MERLIN-Interdictor and MERLIN-1 counter-drone (C-UAS) payloads, which can deploy non-lethal force from the air and entangle hostile drones mid-flight.

    27 min

  7. Jun 3

    This CEO Makes Electric Trucks For UPS, FedEx, & Others – Meet Dakota Semler CEO XOS Trucks -$XOS

    This CEO Makes Electric Trucks For UPS, FedEx, & Others – Meet Dakota Semler CEO XOS Trucks -$XOS Guest Dakota Semler, Chief Executive Officer Dakota Semler is the Chief Executive Officer of Xos, a Los Angeles-based technology company, fleet services provider, and manufacturer of Class 5 through Class 8 battery-electric vehicles. Xos’ mission is to decarbonize commercial transportation with the most durable trucking technology available. Dakota has been in the transportation and trucking industry for more than a decade and grew up working on his family’s fleet business. He came up with the idea for Xos to solve the exact challenge he faced as a fleet operator: to create a cost-effective, durable, and reliable electric vehicle that achieves the same, or better, performance benchmarks of an existing diesel vehicle—without compromising the air we breathe. Since 2018, Xos has deployed hundreds of its 100% battery-electric vehicles with leading fleets within parcel delivery, cash-in-transit, beverage distribution, and linen and textile services. Dakota was named in the Forbes 30 Under 30 in Manufacturing & Industry In 2019. Company information Xos, Inc. www.xostrucks.com. Ticker: NASDAQ: XOS Company Bio: Xos, Inc. (NASDAQ: XOS) is a leading technology company and fleet services provider specializing in battery-electric fleet solutions and mobile energy storage infrastructure. The Company's mobile and stationary energy storage systems are purpose-built for the demanding requirements of commercial and municipal fleet operations. They deliver reliable, cost-effective charging without costly utility upgrades or grid improvements, supported by proprietary fleet management software and fully electric commercial vehicles for seamless operations. Founded in 2016 by Dakota Semler and Giordano Sordoni, Xos was built on a simple premise: the transition from diesel to electric should be as seamless as possible for fleet operators. The Company's integrated portfolio is anchored by its energy storage platform, complemented by fully electric commercial vehicles and powertrain technology for OEM partners, offering fleet operators a comprehensive path to zero-emission operations. Xos has served commercial and municipal operators since 2018 and is trusted by industry leaders including Waymo, Caltrans, FedEx ISPs, UPS, Loomis, and Cintas, among others. Headquartered in Los Angeles, California, with production operations in Byrdstown, Tennessee, the Company went public in August 2021 and trades on NASDAQ under the ticker symbol XOS. For more information, visit www.xostrucks.com.

    22 min

  8. May 28

    The eBay, Amazon, Paypal, Square, Of Latin America – Meet Leandro Cuccioli at Mercado Libre $MELI

    The eBay, Amazon, Paypal, Square, & Stripe Of Latin America – Meet Leandro Cuccioli SVP Of Mercado Libre $MELI Guest Leandro Cuccioli -- SVP, Corporate Development, Strategy, Sustainability, and Investor Relations; Mercado Libre Company Mercado Libre ($MELI) Website http://investor.mercadolibre.com/ Bio Leandro Cuccioli has been Senior Vice President of Corporate Development, Strategy, Sustainability, and Investor Relations at Mercado Libre since July 2024. He has extensive experience in the private sector, having worked in private equity funds investing in the energy, retail, gas, and financial services sectors, with tenures at the UK's sovereign wealth fund and Capital Group, one of the world's largest asset managers. In addition to Latin America, he has professional experience in China, India, and Africa. Between 2016 and 2020, he served in the Argentine government, initially as Public Policy Coordinator in the Cabinet Office of the Chief of Ministers. He then became Deputy Minister of Finance (2017–2018) and later led Argentina's Federal Administration of Public Revenues (AFIP) as Minister of Revenue, overseeing the country's tax collection agency. He holds a degree in Industrial Engineering from the Buenos Aires Institute of Technology (ITBA) and an MBA from the Stanford Graduate School of Business. About Mercado Libre ($MELI) Founded in 1999, MercadoLibre, Inc (NASDAQ: MELI) is the leading company in e-commerce and financial technology in Latin America, with operations in 18 countries. It offers a complete ecosystem of solutions for individuals and businesses to buy, sell, advertise, obtain credit and insurance, collect, send money, save, and pay for goods and services both online and offline. Mercado Libre looks to facilitate access to commerce and financial services in Latin America, a market that offers great opportunities and high growth potential. It uses world-class technology to create intuitive solutions tailored to the local culture to transform the lives of millions of people in the region. More information at http://investor.mercadolibre.com/

    36 min
See All (353)

Trailer

4.9
out of 5
15 Ratings

About

This show interviews the “smart money” (large money managers & CEOs) for timeless investing advice. My goal is to provide you with timeless/actionable advice that you can use to make smarter investment decisions, and help you become intellectually wealthy. The Host: Adam Sarhan, Author, Investor, and Forbes Contributor, interviews real money managers with over $100 million in assets under management (AUM) and CEOs for timeless advice. Disclaimer: All our work is general in nature and for educational/informational purposes only. No specific investment advice is given.

Information

  • Creator
    Adam Sarhan
  • Years Active
    2019 - 2026
  • Episodes
    353
  • Rating
    Clean
  • Copyright
    © Adam Sarhan
  • Show Website
    Smart Money Circle

You Might Also Like